• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Different clinical features of children and adults in regional outbreak of Delta COVID-19.德尔塔变异株引起的区域性疫情中儿童和成人的不同临床特征。
BMC Infect Dis. 2022 Sep 8;22(1):728. doi: 10.1186/s12879-022-07707-6.
2
Comparison of Seroconversion in Children and Adults With Mild COVID-19.儿童和轻症 COVID-19 成人患者血清转换的比较。
JAMA Netw Open. 2022 Mar 1;5(3):e221313. doi: 10.1001/jamanetworkopen.2022.1313.
3
Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection Among Children Aged 0 to 4 Years and Their Household Members.评估 0 至 4 岁儿童及其家庭成员中 SARS-CoV-2 感染的临床和病毒学特征。
JAMA Netw Open. 2022 Aug 1;5(8):e2227348. doi: 10.1001/jamanetworkopen.2022.27348.
4
[Clinical features of children with coronavirus disease 2019 caused by Delta variant infection in different age groups].[不同年龄组Delta变异株感染所致儿童新型冠状病毒肺炎2019的临床特征]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Mar 15;25(3):289-294. doi: 10.7499/j.issn.1008-8830.2209102.
5
Clinical features of children with coronavirus disease 2019 caused by Delta variant infection.德尔塔变异株感染所致儿童 2019 冠状病毒病的临床特征。
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Dec 15;23(12):1267-1270. doi: 10.7499/j.issn.1008-8830.2110043.
6
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.
7
Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreak.比较 SARS-CoV-2 和其他呼吸道病毒引起的儿童急性肺炎:COVID-19 疫情期间的回顾性多中心队列研究。
Mil Med Res. 2021 Feb 16;8(1):13. doi: 10.1186/s40779-021-00306-7.
8
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
9
Unvaccinated Children Are an Important Link in the Transmission of SARS-CoV-2 Delta Variant (B1.617.2): Comparative Clinical Evidence From a Recent Community Surge.未接种疫苗的儿童是 SARS-CoV-2 德尔塔变异株(B1.617.2)传播的重要环节:近期社区疫情中的比较临床证据。
Front Cell Infect Microbiol. 2022 Mar 8;12:814782. doi: 10.3389/fcimb.2022.814782. eCollection 2022.
10
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.

引用本文的文献

1
The Gut Microbiome of Children during the COVID-19 Pandemic.新冠疫情期间儿童的肠道微生物群
Microorganisms. 2022 Dec 13;10(12):2460. doi: 10.3390/microorganisms10122460.

本文引用的文献

1
Cytokine profile in Egyptian children and adolescents with COVID-19 pneumonia: A multicenter study.埃及儿童和青少年 COVID-19 肺炎的细胞因子特征:一项多中心研究。
Pediatr Pulmonol. 2021 Dec;56(12):3924-3933. doi: 10.1002/ppul.25679. Epub 2021 Sep 27.
2
Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients.淋巴细胞亚群改变与 COVID-19 患者的疾病严重程度、影像学表现和延迟住院有关。
BMC Infect Dis. 2021 Jul 1;21(1):631. doi: 10.1186/s12879-021-06354-7.
3
Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.白细胞介素 6(IL-6)抑制剂作为治疗 2019 冠状病毒病(COVID-19)的药物:系统评价和荟萃分析。
J Infect Public Health. 2021 Aug;14(8):1001-1009. doi: 10.1016/j.jiph.2021.06.004. Epub 2021 Jun 15.
4
Liver Chemistries in Patients With COVID-19 Who Were Discharged Alive or Died: A Meta-analysis.新冠病毒疾病(COVID-19)存活出院或死亡患者的肝脏生化指标:一项荟萃分析。
Hepatol Commun. 2020 Sep 15;5(1):12-23. doi: 10.1002/hep4.1585. eCollection 2021 Jan.
5
Clinical characteristics of children with COVID-19: a rapid review and meta-analysis.新冠病毒病患儿的临床特征:快速综述与荟萃分析
Ann Transl Med. 2020 May;8(10):620. doi: 10.21037/atm-20-3302.
6
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.分析 COVID-19 患者的血清细胞因子表明,IL-6 和 IL-10 是疾病严重程度的预测因子。
Emerg Microbes Infect. 2020 Dec;9(1):1123-1130. doi: 10.1080/22221751.2020.1770129.
7
SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc.严重急性呼吸综合征冠状病毒2型与冠状病毒病2019:白细胞介素-6(IL-6)是急性呼吸窘迫综合征发病的“罪魁祸首”吗?除了托珠单抗还有什么?可溶性糖蛋白130融合蛋白(SGP130Fc)
Cytokine X. 2020 Jun;2(2):100029. doi: 10.1016/j.cytox.2020.100029. Epub 2020 May 14.
8
Elevated interleukin-6 and severe COVID-19: A meta-analysis.白细胞介素-6升高与重症新型冠状病毒肺炎:一项荟萃分析。
J Med Virol. 2020 Nov;92(11):2283-2285. doi: 10.1002/jmv.25948. Epub 2020 Jun 2.
9
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.血管紧张素转换酶 2 的器官保护作用及其对 COVID-19 预后的影响。
J Med Virol. 2020 Jul;92(7):726-730. doi: 10.1002/jmv.25785. Epub 2020 Apr 5.
10
Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.中国浙江 36 例 2019 冠状病毒病(COVID-19)患儿的临床和流行病学特征:一项观察性队列研究。
Lancet Infect Dis. 2020 Jun;20(6):689-696. doi: 10.1016/S1473-3099(20)30198-5. Epub 2020 Mar 25.

德尔塔变异株引起的区域性疫情中儿童和成人的不同临床特征。

Different clinical features of children and adults in regional outbreak of Delta COVID-19.

机构信息

Department of Traditional Chinese Medicine, Mengchao Hepatobiliary Hospital of Fujian Medical University, No. 312, Xihong Road, Fuzhou, 350025, Fujian, China.

Department of Infectious Diseases, Affiliated Hospital of Putian College, Putian, Fujian, China.

出版信息

BMC Infect Dis. 2022 Sep 8;22(1):728. doi: 10.1186/s12879-022-07707-6.

DOI:10.1186/s12879-022-07707-6
PMID:36076167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9454403/
Abstract

BACKGROUND

This study compared clinical features of the Delta variant of coronavirus disease 2019 (COVID-19) in children and adults.

METHODS

Clinical data included 80 children and 132 adults with the Delta variant of COVID-19, hospitalized in the Affiliated Hospital of Putian College between September and October 2021. The data was analyzed retrospectively.

RESULTS

The proportion of mild patients in the children group (50%) was higher than that in the adults group (17.9%). Cough (25%, 20/80) and diarrhea (1.3%, 1/80) symptoms in children group were significantly less frequent. Compared with adults, there was no significant difference in the viral load of SARS-CoV-2 in samples collected by nasopharyngeal swabs. In children, lymphocyte count was higher [1.98 (0.25-4.25) vs 1.20 (0.29-4.27) ×10/L], whereas the interleukin-6 level was lower [5.87 (1.50-61.40) vs 15.15 (1.79-166.30) pg/mL] than that in adults group. Additionally, the incidence of liver injury in children group was lower than that in adults group. There was no significant difference in the incidence of proteinuria (22/75 vs 45/112) between the two groups, but the serum creatinine level in children was lower [42.0 (28.0-73.0) vs 57.0 (32.0-94.0) µmol/L].

CONCLUSION

Compared with adults, children with the Delta variant of COVID-19 have differences in symptoms, clinical classification, inflammatory indices, and liver/kidney function injury. Children's illness is relatively mild. Clinicians should pay attention to their differences and use drugs accurately.

摘要

背景

本研究比较了 2019 年冠状病毒病(COVID-19)Delta 变异株在儿童和成人中的临床特征。

方法

临床数据包括 2021 年 9 月至 10 月在莆田学院附属医院住院的 80 例儿童和 132 例成人的 Delta 变异株 COVID-19 患者的临床资料。对这些数据进行回顾性分析。

结果

儿童组轻症患者比例(50%)高于成人组(17.9%)。儿童组咳嗽(25%,20/80)和腹泻(1.3%,1/80)症状发生率明显低于成人组。与成人组相比,鼻咽拭子样本中 SARS-CoV-2 的病毒载量无显著差异。儿童组淋巴细胞计数较高[1.98(0.25-4.25)比 1.20(0.29-4.27)×10/L],白细胞介素-6 水平较低[5.87(1.50-61.40)比 15.15(1.79-166.30)pg/ml]。此外,儿童组肝损伤发生率低于成人组。两组蛋白尿发生率(22/75 比 45/112)无显著差异,但儿童组血肌酐水平较低[42.0(28.0-73.0)比 57.0(32.0-94.0)µmol/L]。

结论

与成人相比,儿童感染 COVID-19 的 Delta 变异株在症状、临床分型、炎症指标和肝/肾功能损伤方面存在差异。儿童病情相对较轻。临床医生应注意这些差异并准确用药。